Oruka Therapeutics (ORKA) Change in Cash (2010 - 2026)

Oruka Therapeutics' Change in Cash history runs 17 years deep, the most recent figure standing at $2.6 million for Q1 2026.

• In Q1 2026, Change in Cash fell 88.25% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at -$34.1 million (down 160.99% YoY), while the FY2025 annual figure was -$14.6 million, down 123.78% from the prior year.
• Change in Cash for Q1 2026 stood at $2.6 million, up from -$44.3 million in the prior quarter.
• The five-year high for Change in Cash was $395.8 million in Q3 2024, with the low at -$349.3 million in Q4 2024.
• The 5-year median for Change in Cash is -$1.6 million (2023), against an average of $2.0 million.
• Peak annual rise in Change in Cash reached 23812.04% in 2024, while the deepest fall reached 32977.65% in 2024.
• Oruka Therapeutics' Change in Cash stood at -$1.5 million in 2022, then rose by 29.32% to -$1.1 million in 2023, then slumped by 32977.65% to -$349.3 million in 2024, then surged by 87.31% to -$44.3 million in 2025, then soared by 105.83% to $2.6 million in 2026.
• Business Quant data shows ORKA's Change in Cash at $2.6 million in Q1 2026, -$44.3 million in Q4 2025, and $25.9 million in Q3 2025.